OSE Immunotherapeutics SA (0RAD) Share Forecast & Price Target
0RAD Analyst Ratings
There are no analyst ratings in the last 3 months.
0RAD Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Nicolas Pauillac | Kepler Capital | EUR 8.20 | buy | 338.97%Upside | Reiterated | 04/30/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Nicolas Pauillac | 04/30/26 | EUR 8.20 | buy | 338.97%Upside | Reiterated | Kepler Capital |
Best Analysts Covering OSE Immunotherapeutics SA
Copying Nicolas Pauillac's trades and holding each position for 3 Months would result in 40.74% of your transactions generating a profit, with an average return of +2.27% per trade.
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 40.74% of your transactions generating a profit, with an average return of +9.72% per trade.
Copying Nicolas Pauillac's trades and holding each position for 2 Years would result in 44.44% of your transactions generating a profit, with an average return of -17.09% per trade.
0RAD Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 0 | 0 | 0 | 0 |
In the current month, 0RAD has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0RAD average Analyst price target in the past 3 months is ―.
0RAD Financial Forecast
0RAD Sales Forecast
Next quarter’s sales forecast for 0RAD is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 1.30M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
